At what enterprise value was AMPLITUDE SURGICAL acquired in 2025?

During the acquisition of AMPLITUDE SURGICAL by ZYDUS in 2025, the transaction's Enterprise Value is estimated to be in the range of €300–700M.

What was the EV/EBITDA of AMPLITUDE SURGICAL when it was acquired by ZYDUS?

The estimated EV/EBITDA multiple for AMPLITUDE SURGICAL is in the range of 10x - 18x.

What was the EV/Revenue multiple of AMPLITUDE SURGICAL when it was acquired by ZYDUS?

The estimated EV/Revenue multiple for AMPLITUDE SURGICAL is in the range of 2x - 6x.

When was AMPLITUDE SURGICAL acquired by ZYDUS?

AMPLITUDE SURGICAL was acquired by ZYDUS in 2025.

What was the revenue of AMPLITUDE SURGICAL at the time of the deal?

The revenue of AMPLITUDE SURGICAL at the time of the deal is estimated to be in the range of €100–200M.

What was the EBITDA of AMPLITUDE SURGICAL during the acquisition?

AMPLITUDE SURGICAL's EBITDA is estimated to be in the range of €10–30M.

How is the data for the AMPLITUDE SURGICAL acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the AMPLITUDE SURGICAL deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://live.euronext.com/fr/products/equities/company-news/2025-03-11-zydus-entre-en-negociations-exclusives-avec-pai-partners

What is the average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026?

The average EV/EBITDA multiple for the Healthcare & Pharma sector in 2026 is 14.3x.

← DATABASE

Home Database Healthcare & PharmaAMPLITUDE SURGICAL

03/2025

AMPLITUDE SURGICAL acquired by ZYDUS

FRANCE Life Sciences / Medical Devices / Implants & Prosthetics EV €300–700M

Context

Zydus entered into exclusive negotiations to acquire a controlling 85.6% stake (block trade) in Amplitude Surgical from PAI Partners, the management and minority shareholders. The offer price is EUR6.25 per share, representing an 80.6% premium over the pre-announcement share price. Following the block acquisition, Zydus will launch a mandatory simplified tender offer (OPAS) to acquire the remaining shares and intends to delist the company (squeeze-out) if the 90% threshold is reached.

AMPLITUDE SURGICAL, which reported an EBITDA margin of [members only] in 2024, is valued in this transaction at an EV/EBITDA multiple of 10x–18x, representing a level close to the average currently observed in the Healthcare & Pharma sector (14.3x).

-> Deep-dive in Healthcare & Pharma market trends

Target

Amplitude Surgical is a leading French MedTech company specializing in the design and manufacture of high-end orthopedic implants for lower-limb surgery (primarily Hip and Knee). Founded in 1997 in Valence, the group positions itself as a premium player, differentiating through a strong technological ecosystem that includes the AMPLIVISION computer-assisted navigation system and the i.M.A.G.E. single-use instrumentation platform. Following the strategic divestment of its foot and ankle division (Novastep) in 2023, the company refocused entirely on its core hip and knee segments, where it holds a strong #2 market position in France.

Ent. Value

€300–700M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

10x–18x

EV / EBIT

[members only]

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Similar deals in Life Sciences

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
04/2025	Knop Investments	AVANCE CARE GROUP	NETHERLANDS	Medical Devices
04/2025	CINVEN	NUTRISENS	FRANCE	Nutrition & Dietary Supplements
03/2025	SIPAREX	LABORATOIRE POLIDIS	FRANCE	Medical Consumables
03/2025	NUTRISENS	PRODIET	BRAZIL	Nutrition & Dietary Supplements
03/2025	LBO FRANCE	HEMODIA	FRANCE	Medical Devices
02/2025	NOVONESIS	FEED ENZYME ALLIANCE	DENMARK	Animal Health
02/2025	EURAZEO / TURENNE CAPITAL / KURMA PARTNERS	GERMITEC	FRANCE	Medical Devices
01/2025	Animalcare Group	Randlab	AUSTRALIA	Animal Health
01/2025	QUADRIVIO GROUP	MIR - MEDICAL INTERNATIONAL RESEARCH	ITALY	Diagnostic Equipment
12/2024	UI INVESTISSEMENT	DIDACTIC	FRANCE	Medical Consumables

REFERENCES

Valuation range: EV €300–700M

Revenue range: €100–200M

EBITDA range: €10–30M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 10x - 18x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of AMPLITUDE SURGICAL by ZYDUS are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.